Pre-Made Efaprinermin Alfa Biosimilar, Fusion Protein targeting TNFRSF18 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting AITR/CD357/ENERGEN/GITR/GITR-D is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Efaprinermin Alfa contains tumor necrosis factor superfamily protein TNFSF18 (human) trimer fusion protein with immunoglobulin g1 (human fc fragment). It is used for the high-value therapeutic targets for inflammatory or immune modulation in autoimmune diseases, transplant recipients, or cancers.